<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00873795</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 09603-001</org_study_id>
    <nct_id>NCT00873795</nct_id>
  </id_info>
  <brief_title>Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major Depression</brief_title>
  <official_title>Efficacy and Safety of Aripiprazole 2.5mg Combine Sertraline 50mg in Major Depression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chimei Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chimei Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      FDA has accepted atypical antipsychotics of olanzapine and aripiprazole as the adjuvant&#xD;
      medications for refractory major depression. But there is still no trial about atypical&#xD;
      antipsychotics combined with antidepressant of SSRI used in fresh major depressive patients.&#xD;
      This project aims to compare the efficacy and tolerability of sertraline with or without&#xD;
      low-dosed aripiprazole added in fresh major depression.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This double-blind, placebo-control, fixed dose, randomized study will be conducted at a&#xD;
      tertiary clinical setting. Patients over 18 y/o fulfilled DSM-IV criteria for major&#xD;
      depression, having a baseline HAM-D score ≧ 14 and a HAM-D item 3 score &lt; 3 will be recruited&#xD;
      into the groups. The study group of patients will receive ten weeks of treatment with a&#xD;
      combination of fix-dosed sertraline and aripiprazole. The control group will received&#xD;
      sertraline only. The score reduction in HAM-D17, CGI, SF-36 and Brief Symptom Rating Scale&#xD;
      (BSRS-50) will be periodically estimated as an efficacy following the use of a SSRIs or and&#xD;
      aripiprazole.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>score change of Hamilton Rating Scale For Depression (HAM-D17 )</measure>
    <time_frame>day 1 / 1 week / 2 weeks/ 4 weeks/ 6 weeks/ 10weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>score change of Brief Psychiatric Rating Scale (BPRS-50)</measure>
    <time_frame>day 1/ 1 week / 2 weeks/ 4 weeks/ 6 weeks/ 10 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>aripiprazole and sertraline</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients of this arm receive ten weeks of treatment with a combination of sertraline 50mg/day and aripiprazole 2.5mg/day.The effect of this arm is assessed for HAM-D17, CGI, SF-36 and BSRS-50.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sertraline and placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The patients of this arm receive ten weeks of treatment with a combination of sertraline 50mg/day and placebo.The effect of this arm is assessed for HAM-D17, CGI, SF-36 and BSRS-50.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>aripiprazole , sertraline</intervention_name>
    <description>In this ten weeks,double-blind,placebo-control,randomized,fixed dose study, study,subjects were randomly assigned to treatment with aripiprazole 2.5mg/day plus sertraline 50mg/day or sertraline 50mg/day plus placebo.</description>
    <arm_group_label>aripiprazole and sertraline</arm_group_label>
    <arm_group_label>sertraline and placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female subjects 18 to 65 years inclusive.&#xD;
&#xD;
          -  Fulfilled DSM-Ⅳ criteria for major depressive disorder.&#xD;
&#xD;
          -  Onset ≧2 weeks.&#xD;
&#xD;
          -  Baseline score ≧14 on the HAM-D17.&#xD;
&#xD;
          -  Written informed consent prior to entry into the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  HAM-D17 item 3 score≧3.&#xD;
&#xD;
          -  Life-time history of bipolar disorders, schizophrenia or schizoaffective disorder.&#xD;
&#xD;
          -  Current history of panic disorder, obsessive-compulsive disorder, alcohol or substance&#xD;
             abuse.&#xD;
&#xD;
          -  Mood disorder due to general medical condition.&#xD;
&#xD;
          -  Treatment with antidepressants at entry into the study before 2 weeks.&#xD;
&#xD;
          -  Need for psychoactive medications other than the study drugs, except for one&#xD;
             benzodiazepine or hypnotic given at a stable dose.&#xD;
&#xD;
          -  Known intolerance or inefficacy to either drug.&#xD;
&#xD;
          -  Previous lack of response to two or more antidepressants at adequate dosage.&#xD;
&#xD;
          -  Subjects who have acute or unstable medical illness or organic failure.&#xD;
&#xD;
          -  Pregnancy and breast-feeding.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fong-Lin Jang, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Chimei Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Psychiatry Department, Chimei Medical Center</name>
      <address>
        <city>Tainan</city>
        <zip>700</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>April 2009</verification_date>
  <study_first_submitted>March 31, 2009</study_first_submitted>
  <study_first_submitted_qc>April 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2009</study_first_posted>
  <last_update_submitted>April 1, 2009</last_update_submitted>
  <last_update_submitted_qc>April 1, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Fong-Lin Jang</name_title>
    <organization>Chi Mei Medical Center</organization>
  </responsible_party>
  <keyword>efficacy</keyword>
  <keyword>tolerability</keyword>
  <keyword>combination of aripiprazole and SSRI(sertraline)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aripiprazole</mesh_term>
    <mesh_term>Sertraline</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>August 19, 2012</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>August 20, 2012</submitted>
    <returned>September 17, 2012</returned>
    <submitted>May 28, 2014</submitted>
    <returned>June 27, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

